top of page
Search
Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement
Anchiano Therapeutics Ltd. (“Anchiano”) (Nasdaq: ANCN), a preclinical biopharmaceutical company, and Chemomab Ltd. (“Chemomab”), a...

SBIJI Innovation
Jan 4, 20211 min read
Biosight Closes $46M Series C Financing to Advance Clinical Oncology Programs
Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders,...

SBIJI Innovation
Dec 13, 20201 min read
D-Fend Solutions expands US headquarters!
Nov. 12th 2020 D-Fend Solutions has opened its first North American office in McLean, Virginia, to expand its operations and meet the...

SBIJI Innovation
Dec 13, 20201 min read
Alstom has finalised a deal to invest US$7 million in Cylus, an Israel-based cybersecurity specialis
9 December 2020 – Alstom has finalised a deal to invest US$7 million in Cylus, an Israel-based cybersecurity specialist, thus acquiring a...

SBIJI Innovation
Dec 13, 20201 min read
BiomX Announces Preclinical Results of Analysis of Patient Samples and Engineering of Phage
BiomX Announces Preclinical Results of Analysis of Patient Samples and Engineering of Phage for Therapeutic Applications in Colorectal...

SBIJI Innovation
Dec 13, 20201 min read
bottom of page